Related Experiment Videos
Treatment of respiratory syncytial virus infections in children
M J Mäkelä1, O Ruuskanen, P L Ogra
1Department of Paediatrics, Turku University Hospital, Finland.
Insights
This study clarifies respiratory syncytial virus (RSV) bronchiolitis management. Hospitalization is for hypoxemia, with oxygen therapy, while mist and physiotherapy are ineffective for RSV treatment.
Area of Science:
- Pediatrics
- Infectious Diseases
- Pulmonology
Background:
- Respiratory syncytial virus (RSV) infections, particularly bronchiolitis, present varied treatment approaches globally.
- Recent studies aim to standardize and clarify optimal management strategies for RSV bronchiolitis.
Purpose of the Study:
- To provide clear, evidence-based guidelines for managing infants diagnosed with respiratory syncytial virus (RSV) bronchiolitis.
- To evaluate the efficacy of various therapeutic interventions for RSV infections.
Main Methods:
- Review and synthesis of recent clinical studies and data on RSV bronchiolitis management.
- Analysis of treatment outcomes based on oxygenation levels, medication efficacy, and supportive care.
Main Results:
- Hospitalization is indicated for infants with RSV bronchiolitis experiencing insufficient oxygenation (hypoxemia), requiring supplemental oxygen.
- Bronchodilators are the preferred pharmacological intervention; mist treatments and physiotherapy show no benefit.
- Corticosteroids lack strong supporting data, and antibiotics are reserved for confirmed bacterial co-infections.
- Ribavirin is recommended only for high-risk, immunocompromised pediatric patients.
- Future treatments may include immunotherapy (e.g., aerosolized IgG), and current infection control relies on cohort nursing and gowns.
Conclusions:
- Standardized management for RSV bronchiolitis emphasizes oxygenation support and judicious use of bronchodilators.
- Non-beneficial treatments like mist and physiotherapy should be avoided.
- Antibiotics and corticosteroids are generally not indicated for uncomplicated RSV bronchiolitis.
- Infection control measures are crucial for preventing nosocomial spread pending vaccine availability.
Abstract:
Treatment of the infections caused by the respiratory syncytial virus (RSV) has varied largely in different centres. Recently, however, management practices have become more clear based on a number of studies. An infant with RSV bronchiolitis should be hospitalized in case of insufficient oxygenation, as measured by pulse oximetry, and additional oxygen should be supplied. Mist treatment and physiotherapy are not beneficial. Bronchodilators seem to be the drug of choice in most infants with bronchiolitis. Use of corticosteroids has not been supported by data received from most studies although they are generally used. Ribavirin should be used only with high-risk patients such as immunosuppressed children. Despite the common prescription of antibiotics, they should only be given to patients with verified bacterial infection. In the future, immunotherapy including aerosolized IgG may be an alternative in treatment of RSV infections. Until an efficient vaccine is brought to clinical use, the best way to limit nosocomial spread of infections is to use cohort nursing and gowns.